Mark Corrigan - 07 Aug 2023 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Reporting relationship: Director
Issuer ticker: WVE
Reported as of: 07 Aug 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Aug 2023, 20:00:21 UTC
Prior SEC filing: 20 Jul 2023
Next SEC filing: 14 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Mark Corrigan

Key filing fact

Mark Corrigan filed Form 4 for Wave Life Sciences Ltd. (WVE) on 09 Aug 2023.

Key facts

This page summarizes Mark Corrigan's Form 4 filing for Wave Life Sciences Ltd. (WVE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Aug 2023, 20:00.

Change

Previous filing in this sequence was filed on 20 Jul 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WVE transaction Derivative

Share Option (right to buy)

Award

Transaction value: $0
Shares: +45,000
Change %
Price: $0.000000
Shares after: 45,000
Date: 07 Aug 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 45,000
Exercise price: $4.58
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2024 annual general meeting or August 7, 2024.